References
- Magill SS, Edwards JR, Bamberg W, et al. Multistate point-prevalence survey of health care–associated infections. N Engl J Med. 2014 Mar 27;370(13):1198–1208.
- Lessa FC, Mu Y, Bamberg WM, et al. Burden of Clostridium difficile infection in the United States. N Engl J Med. 2015 Feb 26;372(9):825–834.
- Steiner C, Barrett M, Sun Y, et al. HCUP projections: clostridium difficile hospitalizations 2001 to 2013. Agency for healthcare research and quality; 2014; Available from: https://www.hcup-us.ahrq.gov/reports/projections/2014–03.pdf. [Accessed 2017 Oct 3.
- Zhang S, Palazuelos-Munoz S, Balsells EM, et al. Cost of hospital management of Clostridium difficile infection in United States-a meta-analysis and modelling study. BMC Infect Dis. 2016 Aug 25;16(1):447.
- Davis KW, Hanners RE, Lockwood SM. Implementation of a proton pump inhibitor stewardship program. Am J Health Syst Pharm. 2017 Jun 15;74(12):932–937.
- Trifan A, Stanciu C, Girleanu I, et al. Proton pump inhibitors therapy and risk of Clostridium difficile infection: systematic review and meta-analysis. World J Gastroenterol. 2017 Sep 21;23(35):6500–6515.
- Wahking RA, Steele RL, Hanners RE, et al. Outcomes from a pharmacist - led proton pump inhibitor stewardship program at a single institution. Hosp Pharm. 2018 Feb;53(1):59–67.
- Barletta JF, Kanji S, MacLaren R, et al. Pharmacoepidemiology of stress ulcer prophylaxis in the United States and Canada. J Crit Care. 2014 Dec;29(6):955–960.
- Barletta JF, El-Ibiary SY, Davis LE, et al. Proton pump inhibitors and the risk for hospital-acquired clostridium difficile infection. Mayo Clin Proc. 2013 Oct;88(10):1085–1090.
- Barletta JF, Sclar DA. Proton pump inhibitors increase the risk for hospital-acquired Clostridium difficile infection in critically ill patients. Crit Care. 2014 Dec 24;18(6):714.
- Faleck DM, Salmasian H, Furuya EY, et al. Proton pump inhibitors do not increase risk for clostridium difficile infection in the intensive care unit. Am J Gastroenterol. 2016 Nov;111(11):1641–1648.
- Krag M, Perner A, Wetterslev J, et al. Stress ulcer prophylaxis in the intensive care unit: is it indicated? A topical systematic review. Acta Anaesthesiol Scand. 2013 Aug;57(7):835–847.
- MacLaren R, Reynolds PM, Allen RR. Histamine-2 receptor antagonists vs proton pump inhibitors on gastrointestinal tract hemorrhage and infectious complications in the intensive care unit. JAMA Intern Med. 2014 Apr;174(4):564–574.
- Selvanderan SP, Summers MJ, Finnis ME, et al. Pantoprazole or placebo for stress ulcer prophylaxis (POP-UP): randomized double-blind exploratory study. Crit Care Med. 2016 Oct;44(10):1842–1850.
- Wilder-Smith CH, Bondarov P, Lundgren M, et al. Intravenous esomeprazole (40 mg and 20 mg) inhibits gastric acid secretion as effectively as oral esomeprazole: results of two randomized clinical studies. Eur J Gastroenterol Hepatol. 2005 Feb;17(2):191–197.
- Goldberger AL, Amaral LA, Glass L, et al. PhysioBank, physiotoolkit, and physioNet: components of a new research resource for complex physiologic signals. Circulation. 2000 Jun 13;101(23):E215–20.
- Saeed M, Villarroel M, Reisner AT, et al. Multiparameter intelligent monitoring in intensive care II: a public-access intensive care unit database. Crit Care Med. 2011 May;39(5):952–960.
- Scott DJ, Lee J, Silva I, et al. Accessing the public MIMIC-II intensive care relational database for clinical research. BMC Med Inform Decis Mak. 2013 Jan;10(13):9.
- Reveles KR, Lee GC, Boyd NK, et al. The rise in Clostridium difficile infection incidence among hospitalized adults in the United States: 2001-2010. Am J Infect Control. 2014 Oct;42(10):1028–1032.
- Dubberke ER, Reske KA, McDonald LC, et al. ICD-9 codes and surveillance for Clostridium difficile-associated disease. Emerg Infect Dis. 2006 Oct;12(10):1576–1579.
- Greenland S. Modeling and variable selection in epidemiologic analysis. Am J Public Health. 1989 Mar;79(3):340–349.
- Freedberg DE, Toussaint NC, Chen SP, et al. Proton pump inhibitors alter specific taxa in the human gastrointestinal microbiome: a crossover trial. Gastroenterology. 2015 Oct;149(4):883–5.e9.